Dietary treatment with rice containing resistant starch improves markers of endothelial function with reduction of postprandial blood glucose and oxidative stress in patients with prediabetes or newly diagnosed type 2 diabetes

Atherosclerosis. 2012 Oct;224(2):457-64. doi: 10.1016/j.atherosclerosis.2012.08.003. Epub 2012 Aug 27.

Abstract

Objective: We aimed to evaluate whether 4-week of dietary treatment with rice containing resistant starch reduces blood glucose and oxidative stress as well as improves endothelial function.

Methods: Patients with impaired fasting glucose (IFG), impaired glucose tolerance (IGT) or newly diagnosed type 2 diabetes (n = 90) were randomly assigned to either a group ingesting rice containing 6.51 g resistant starch daily or a control rice group for 4-weeks. We assessed fasting and postprandial levels of glucose and insulin, oxidative stress markers and endothelial function using reactive hyperemia peripheral arterial tonometry (RH-PAT).

Results: The diet containing rice with resistant starch reduced fasting insulin and insulin resistance, postprandial glucose (P = 0.010) and insulin levels at 30 min, and glucose and insulin areas under the response curve after the standard meal. Rice with resistant starch also decreased urinary 8-epi-PGF(2α) and plasma malondialdehyde (MDA) and increased the RH-PAT index (P < 0.001) and total nitric oxide (NO). Postprandial changes in glucose at 60 and 120 min and areas under the glucose response curve, MDA, RH-PAT, and total NO of the test group differed significantly from those in the control even after adjusting for baseline values. Overall, changes in the RH-PAT index correlated positively with changes in total NO (r = 0.336, P = 0.003) and superoxide dismutase activity (r = 0.381, P = 0.001) and negatively with changes in MDA (r = -0.358, P = 0.002) and 8-epi-PGF(2α).

Conclusions: In patients with IFG, IGT or newly diagnosed type 2 diabetes, 4-weeks of dietary treatment with rice containing resistant starch was associated with improved endothelial function with reduction of postprandial glucose and oxidative stress compared with control.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / blood
  • Biomarkers / urine
  • Blood Glucose / metabolism*
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / diagnosis
  • Diabetes Mellitus, Type 2 / diet therapy*
  • Diabetes Mellitus, Type 2 / physiopathology
  • Digestion
  • Dinoprost / analogs & derivatives
  • Dinoprost / urine
  • Double-Blind Method
  • Endothelium, Vascular / metabolism
  • Endothelium, Vascular / physiopathology*
  • Female
  • Humans
  • Hydrolysis
  • Hyperemia / physiopathology
  • Insulin / blood
  • Insulin Resistance
  • Male
  • Malondialdehyde / blood
  • Manometry
  • Middle Aged
  • Nitric Oxide / blood
  • Oryza / genetics
  • Oryza / metabolism*
  • Oxidative Stress*
  • Plants, Genetically Modified / genetics
  • Plants, Genetically Modified / metabolism*
  • Postprandial Period
  • Prediabetic State / blood
  • Prediabetic State / diagnosis
  • Prediabetic State / diet therapy*
  • Prediabetic State / physiopathology
  • Republic of Korea
  • Starch / metabolism*
  • Superoxide Dismutase / blood
  • Time Factors
  • Treatment Outcome

Substances

  • Biomarkers
  • Blood Glucose
  • Insulin
  • 8-epi-prostaglandin F2alpha
  • Nitric Oxide
  • Malondialdehyde
  • Starch
  • Dinoprost
  • Superoxide Dismutase